COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Proximal Resistance Training for People With Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Other: Proximal Resistance Training

First Posted Date: 2020-09-14

Last Posted Date: 2023-11-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 34

Registration Number: NCT04548154

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

The GAIN Study: Understanding What Helps Children Learn to Like and Eat New Foods

Completed

Conditions: Parenting
Food Preferences

First Posted Date: 2020-09-10

Last Posted Date: 2020-09-10

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 58

Registration Number: NCT04544332

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Phase 1

Recruiting

Conditions: B-cell Non Hodgkin Lymphoma
B-cell Acute Lymphoblastic Leukemia

Interventions: Drug: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells

First Posted Date: 2020-09-10

Last Posted Date: 2024-12-06

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 50

Registration Number: NCT04544592

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19

Not Applicable

Completed

Conditions: Covid19

Interventions: Diagnostic Test: Lung ultrasound use in patients hospitalized with COVID

First Posted Date: 2020-09-09

Last Posted Date: 2023-03-13

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 384

Registration Number: NCT04542421

Locations: 🇺🇸
University of Colorado, Denver, Colorado, United States

Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease

Phase 1

Completed

Conditions: Non Small Cell Lung Cancer
CNS Progression

Interventions: Drug: Temozolomide plus Osimertinib
Drug: Temozolomide plus Lorlatinib

First Posted Date: 2020-09-09

Last Posted Date: 2023-05-16

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1

Registration Number: NCT04541407

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Novel Approaches for Quantitative Assessment of Adherence

Completed

Conditions: Healthy

Interventions: Other: Adenine 5+ (five stable-labeled nitrogens)

First Posted Date: 2020-09-02

Last Posted Date: 2024-05-22

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 15

Registration Number: NCT04535934

Locations: 🇺🇸
University of Colorado- Anschutz Medical Campus, Aurora, Colorado, United States

Shared Decision Making Aid for Prosthetic Design

Conditions: Amputation
Prosthesis User

Interventions: Other: Qualitative focus group interviews
Other: Qualitative semi-structured interviews

First Posted Date: 2020-09-02

Last Posted Date: 2022-02-24

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 62

Registration Number: NCT04536025

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients

Phase 3

Active, not recruiting

Conditions: Disease Attributes
Critical Illness
Pathologic Processes
Wounds and Injury

Interventions: Other: Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

First Posted Date: 2020-09-01

Last Posted Date: 2024-04-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 6000

Registration Number: NCT04534959

Locations: 🇺🇸
University of Alabama-Birmingham Medical Center, Birmingham, Alabama, United States
🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
🇺🇸
Oregon Health and Sciences University, Portland, Oregon, United States

and more 5 locations

POLA+BR for Relapsed or Refractory DLBCL

Phase 2

Withdrawn

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Polatuzumab Vedotin

First Posted Date: 2020-09-01

Last Posted Date: 2022-05-09

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT04535102

Strategy to Avoid Excessive Oxygen in Major Burn Patients

Phase 3

Active, not recruiting

Conditions: Disease Attributes
Pathologic Processes
Wounds and Injury
Critical Illness

Interventions: Other: Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

First Posted Date: 2020-09-01

Last Posted Date: 2024-04-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 2000

Registration Number: NCT04534972

Locations: 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸
Army Institute of Surgical Research, San Antonio, Texas, United States
🇺🇸
University of Alabama-Birmingham Medical Center, Birmingham, Alabama, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy